Company / Return on Assets (ROA)
Ginkgo Bioworks Holdings, Inc. Return on Assets (ROA) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-27.9%
FY2025
5-year range
-88.4% / -27.9%
FY2021-FY2025
Trend
+29.7%
vs FY2024
Sector context
#126 of 213
Health Care
What the data says
At -27.9%, Ginkgo Bioworks Holdings, Inc.'s return on assets (roa) ranks #126 of 213 in the Health Care sector. Return on Assets (ROA) has increased for 4 consecutive years, from -88.4% in FY2021 to -27.9% in FY2025.
Based on SEC 10-K filings.
-27.9% in FY2025 with a 5-year CAGR of -9.2%.
Improved from -53.6% to -27.9% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +55.0pp
- 5-Year Change
- -9.2pp
- 10-Year Change
- -
Sector benchmark
#126 of 213 in Health CareTop 59% of 213This company -27.9% Sector average -24.1%
▼
-16.1% below sector average
Key checks
Key Insights
- Ginkgo Bioworks Holdings, Inc.'s return on assets (roa) has grown for 4 consecutive years.
- In FY2025, return on assets (roa) increased 29.7% year-over-year.
- Currently 3.9pp below the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -27.9% | +29.7% |
| FY2024 | -39.7% | +25.9% |
| FY2023 | -53.6% | +35.3% |
| FY2022 | -82.9% | +6.2% |
| FY2021 | -88.4% | -371.3% |
| FY2020 | -18.8% | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026